Pulmonary vascular disease

Pulmonary vascular disease

Is right heart catheterisation still a fundamental part of the follow-up assessment of pulmonary arterial hypertension? The argument against
Luke S. Howard

European Respiratory Journal Jul 2018, 52 (1) 1800996; DOI: 10.1183/13993003.00996-2018
Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension
Grayson L. Baird, Christine Archer-Chicko, R. Graham Barr, David A. Bluemke, Andrew E. Foderaro, Jason S. Fritz, Nicholas S. Hill, Steven M. Kawut, James R. Klinger, Joao A.C. Lima, Christopher J. Mullin, Pamela Ouyang, Harold I. Palevsky, Amy J. Palmisicano, Diane Pinder, Ioana R. Preston, Kari E. Roberts, K. Akaya Smith, Thomas Walsh, Mary Whittenhall, Corey E. Ventetuolo

European Respiratory Journal Jun 2018, 51 (6) 1800467; DOI: 10.1183/13993003.00467-2018
In-depth haemodynamic phenotyping of pulmonary hypertension due to left heart disease
Christian Gerges, Mario Gerges, Pierre Fesler, Anna Maria Pistritto, Nicholas P. Konowitz, Johannes Jakowitsch, David S. Celermajer, Irene M. Lang

European Respiratory Journal May 2018, 51 (5) 1800067; DOI: 10.1183/13993003.00067-2018
Management appropriateness and outcomes of patients with acute pulmonary embolism
David Jiménez, Behnood Bikdeli, Deisy Barrios, Raquel Morillo, Rosa Nieto, Ina Guerassimova, Alfonso Muriel, Luis Jara-Palomares, Lisa Moores, Victor Tapson, Roger D. Yusen, Manuel Monreal

European Respiratory Journal May 2018, 51 (5) 1800445; DOI: 10.1183/13993003.00445-2018
Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension
Clara Hjalmarsson, Göran Rådegran, David Kylhammar, Bengt Rundqvist, Jonas Multing, Magnus D. Nisell, Barbro Kjellström

European Respiratory Journal May 2018, 51 (5) 1702310; DOI: 10.1183/13993003.02310-2017
Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study
Kristian Hellenkamp, Piotr Pruszczyk, David Jiménez, Anna Wyzgał, Deisy Barrios, Michał Ciurzyński, Raquel Morillo, Lukas Hobohm, Karsten Keller, Katarzyna Kurnicka, Maciej Kostrubiec, Rolf Wachter, Gerd Hasenfuß, Stavros Konstantinides, Mareike Lankeit

European Respiratory Journal Apr 2018, 51 (4) 1702037; DOI: 10.1183/13993003.02037-2017
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis
J. Gerry Coghlan, Matthias Wolf, Oliver Distler, Christopher P. Denton, Martin Doelberg, Satenik Harutyunova, Alberto M. Marra, Nicola Benjamin, Christine Fischer, Ekkehard Grünig

European Respiratory Journal Apr 2018, 51 (4) 1701197; DOI: 10.1183/13993003.01197-2017
Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism
Nicolas Coquoz, Daniel Weilenmann, Daiana Stolz, Vladimir Popov, Andrea Azzola, Jean-Marc Fellrath, Hans Stricker, Alberto Pagnamenta, Sebastian Ott, Silvia Ulrich, Sandor Györik, Jérôme Pasquier, John-David Aubert

European Respiratory Journal Apr 2018, 51 (4) 1702505; DOI: 10.1183/13993003.02505-2017
Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension
Oleg Pak, Susan Scheibe, Azadeh Esfandiary, Mareike Gierhardt, Akylbek Sydykov, Angela Logan, Athanasios Fysikopoulos, Florian Veit, Matthias Hecker, Florian Kroschel, Karin Quanz, Alexandra Erb, Katharina Schäfer, Mirja Fassbinder, Nasim Alebrahimdehkordi, Hossein A. Ghofrani, Ralph T. Schermuly, Ralf P. Brandes, Werner Seeger, Michael P. Murphy, Norbert Weissmann, Natascha Sommer

European Respiratory Journal Mar 2018, 51 (3) 1701024; DOI: 10.1183/13993003.01024-2017
The ROS controversy in hypoxic pulmonary hypertension revisited
Sébastien Bonnet, Olivier Boucherat

European Respiratory Journal Mar 2018, 51 (3) 1800276; DOI: 10.1183/13993003.00276-2018

Main menu

User menu

Search

Pulmonary vascular disease

Pages

Contact us